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Abstract
Public health policy/law is a discipline that seeks to identify opportunities and implement mechanisms
to achieve justice in the public health sector. Several public health policies and programs have been
implemented by virtue of the Affordable Care Act (ACA), and these policies and programs seek to decrease
America’s “paradox of excess and deprivation” and address socioeconomic barriers that exist in the U.S.
healthcare system. Private healthcare market interests have accused the ACA of intruding heavily into
the professional autonomy of the medical profession, eroding healthcare market competition, and driving
up national healthcare spending. Counter-arguments defending the ACA state that the law exposes the
limitations to such professional autonomy of the medical profession, primarily because the U.S. healthcare
system is currently ridden with excess, waste, and social injustice. This review article outlines the types
of policies and laws governing healthcare, unique healthcare issues faced by particularly vulnerable
populations, and future challenges and opportunities under the ACA. Lastly, the article provides
recommendations to address future challenges and opportunities under the ACA, so as to balance the
scales between private market interests and public health equity.

Author Bio(s)
Rachele Hendricks-Sturrup is a biomedical scientist and health policy analyst, and holds a Bachelor of
Science in Biology, a Master of Science in Pharmacology and Toxicology, and a Master of Art in Legal
Studies. She is currently pursuing a Doctor of Health Science at Nova Southeastern University. Her doctoral
study focus involves exploring and describing how various forms of biotechnology can be used within the
scope of personalized medicine and value-based care.

This opinion piece is available in Internet Journal of Allied Health Sciences and Practice:
https://nsuworks.nova.edu/ijahsp/vol14/iss4/9

Dedicated to allied health professional practice and education
Vol. 14 No. 4 ISSN 1540-580X

Issues and Challenges: The Development of Fair and Equitable Health Policy
Rachele Hendricks-Sturrup
Nova Southeastern University
United States
ABSTRACT
Public health policy/law is a discipline that seeks to identify opportunities and implement mechanisms to achieve justice in the
public health sector. Several public health policies and programs have been implemented by virtue of the Affordable Care Act
(ACA), and these policies and programs seek to decrease America’s “paradox of excess and deprivation” and address
socioeconomic barriers that exist in the U.S. healthcare system. Private healthcare market interests have accused the ACA of
intruding heavily into the professional autonomy of the medical profession, eroding healthcare market competition, and driving up
national healthcare spending. Counter-arguments defending the ACA state that the law exposes the limitations to such professional
autonomy of the medical profession, primarily because the U.S. healthcare system is currently ridden with excess, waste, and
social injustice. This review article outlines the types of policies and laws governing healthcare, unique healthcare issues faced by
particularly vulnerable populations, and future challenges and opportunities under the ACA. Lastly, the article provides
recommendations to address future challenges and opportunities under the ACA, so as to balance the scales between private
market interests and public health equity.
Introduction
Public health policy/law concentrates on understanding and formulating ways to achieve a delicate balance between the business
autonomy of the private healthcare market and government regulation of the private healthcare market. 1 A major and current
example of a public health policy/law is the Patient Protection and Affordable Care Act (commonly referred to as the “ACA”). The
ACA (42 U.S.C. § 18001) was signed into law by President Barack Obama and upheld by the Supreme Court in 20122. 2
Private market interests have since challenged the ACA, citing that the law intrudes heavily into the professional autonomy of the
medical profession, erodes healthcare market competition, and drives up healthcare spending in the form of pent-up demand.1
Counter-arguments defending the ACA state that the law exposes the limitations to such autonomy over the medical profession,
as the U.S. healthcare system is ridden with excess, waste, and social injustice. Additional examples of these limitations are as
follows: 1) the majority of our healthcare system is currently paid based on its volume versus its provided value; 2) the U.S.
experiences poorer health outcomes than other developed nations despite the fact that the U.S. spends the more on its healthcare
than any other developed nation; and 3) there is a lack of full stakeholder engagement to provide better coordinated and informed
care to patient populations.
Public health policy seeks to balance the scales between government and private market interests. The ACA is a timely example
of added weight to the scale of public health governance to counter-balance the weight of the private healthcare market. Competing
interests between these two forces date back to the beginning of the twentieth century, with the ACA’s weight resembling that of
the Social Security Amendments of 1965, our government’s second most recent quantum leap toward equitable healthcare for
those of low socioeconomic status. The discussion below outlines the types of policies and laws governing healthcare, unique
healthcare issues faced by particularly vulnerable populations, and future challenges and opportunities under the ACA. Lastly, the
article provides brief recommendations on best practices to address future challenges presented by the ACA.
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Policies and Laws Governing Healthcare
The philosophical sub-discipline of bioethics plays a major role in healthcare legislation. Thus, there are two traditional types of
policies and laws governing healthcare: 1) those defining the function and power of public health agencies, and 2) those directly
serving to protect and promote public health. Together, these two types of policies and laws promulgate both the power and
intentions of the government to preserve the health of the population.1
The executive branch of the federal government implements and enforces laws and appoints heads of federal government
agencies. The U.S. Department of Health and Human Services (HHS) is the cabinet-level department of the U.S. government that
oversees and addresses human health issues and defines the function and power of its several operating divisions and agencies.
Some HHS agencies include the Centers for Medicare and Medicaid Services (CMS) and the Substance Abuse and Mental Health
Services Administration. The HHS is tasked with oversight of the ACA; however, the Internal Revenue Service is responsible for
overseeing the tax provisions within the ACA.
Governments have the ability to incentivize and promote healthy consumer behavior not only via legislation at the federal and state
level, such as through the ACA, but also at the city level. For example, in order to address the current obesity epidemic, the city of
Berkeley, California, implemented a Pigovian tax that is charged to distributors of certain sugar-sweetened beverages such as
sweetened teas and soda (also called “Measure D”). This city ordinance caused for a tax levy of “one cent ($0.01) per fluid ounce
on the privilege of distributing sugar-sweetened beverage products in the city.”3 Although unsuccessful, the American Beverage
Association, a private market interest, spent millions of dollars publicly opposing Measure D. 4 In essence, Measure D serves to
balance its governmental scale against private market interests in order to protect the public health of the city of Berkeley,
California.
Unique Healthcare Issues of Vulnerable Populations
Financially vulnerable populations encompass those living at or slightly above the federal poverty level, while clinically vulnerable
populations include those with high-risk, chronic conditions (such as cancer). These two populations exist both separately and
combined, and equally struggle to afford ever-increasing and expensive out-of-pocket expenses in the form of insurance premiums,
co-insurance, co-payments, and deductibles. Prior to the ACA, insurance payers were allowed to deny insurance coverage to
patients with pre-existing conditions, thereby exacerbating the socioeconomic issue of unaffordable coverage and compromised
health in low income populations with high-risk, chronic conditions.5
Clinically vulnerable populations also include those with mental/behavioral health issues such as substance abuse disorders.
Substance abuse occurs in various forms; alcoholism and non-medical use of prescription medications such as opiates, sedatives,
pain-killers, and tranquilizers fall under the category of substance abuse. Patients with mental health and substance abuse issues,
along with other medical conditions such as cancer, encompass two-thirds of high-use, high-cost patient spending in the healthcare
system.6 Current studies also demonstrate a positive correlation between socioeconomic status, and substance abuse and mental
disorders.7,8,9
The forms of laws and regulations described above seek to protect and/or improve the health of vulnerable populations, and
balance the scales between bioethics and business. The ACA is coined as a pivotal moment in our healthcare system’s history
that, among several of its provisions and programs, increased access to care for millions of individuals. Examples include, but are
not limited to, expanded Medicaid coverage to individuals living at or below 138% of the poverty level, government subsidized
commercial health coverage for qualifying individuals living above 138% but below 400% of the federal poverty level, and access
to care for high-risk cancer patient populations that were previously denied insurance coverage for their pre-existing condition.1
Further, the ACA requires that health insurance sold to newly eligible adults on Health Insurance Exchanges or provided under
Medicaid include coverage for substance abuse treatment.10 Table 1 provides a general overview of the ACA’s key provisions, and
includes brief descriptions of how those features affect individuals and families, health care providers, insurers, employers, and
taxpayers.15
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ACA TITLE
TITLE I- Quality, affordable
health care for all
Americans

-

TITLE II- Role of public
programs

-

TITLE III- Improving the
quality and efficiency of
health care

-

TITLE IV- Prevention of
chronic disease and
improving public health

-

TITLE V- Health care
workforce

-

-
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Table 1. Key Features of the ACA Titles I-X
Key Features
Americans without health insurance coverage are given the ability to select
personalized health insurance coverage on public market exchanges.
Discrimination is prohibited, such that insurers may no longer deny health
insurance coverage to individuals and children with pre-existing medical
conditions.
Young adults under age 26 may remain on their parents’ health coverage plans.
States given flexible options to establish basic health programs for low-income
individuals through State Medicaid and other health subsidy programs.
Tax incentives and cost-sharing reductions are provided to individuals enrolled in
qualified health plans.
Employers are held responsible for informing employees of available health
coverage options, and Large Employersa are required to provide automatic
enrollment to their employees.
Expanded Medicaid coverage to individuals and families living at or below 138
percent of the federal poverty level.
Simplified Medicaid and Children's Health Insurance Program (CHIP) enrollment
procedures.
Improved quality of Medicaid services, which includes support for both pregnant
and parenting teens and women, expanded Medicaid reimbursement, and
rebates for prescription drugs.
The development and inclusion of a core, recommended set of adult health quality
measures under the Medicaid Quality Measurement Program; measures shall be
reported to the CMS in a standardized format and on behalf of Medicaid
beneficiaries.
Medicare payments are linked to quality outcomes, versus patient volume,
through the development and use of quality reporting and physician feedback
programs and value-based modifiers under the physician fee schedule, and by
virtue of national strategy to improve health care quality.
The development of innovative patient care models, such as the Medicare Shared
Savings Program and payment bundling for clinical episodes.
Ensured beneficiary access to clinical care and services, including mental health
and ambulatory services, and integration of quality improvement and patient
safety training and education programs for health professionals.
Improved payment accuracy and payment adjustments for specified services and
products, including home health care and biosimilar products, and payment
protections for rural health care providers.
Funding commitments to programs that promote illness prevention, wellness, and
contribute to the public health.
Increased and improved access to preventative health services for Medicare and
Medicaid beneficiaries.
Funding for employment incentives, such as scholarships and loan repayment
programs, to increase the number of primary care physicians, nurses, physician
assistants, mental health providers, and dental health providers in medically
underserved areas.

Note: a “Large Employer” as defined under Section 1304 of the ACA; “in connection with a group health plan with respect to a
calendar year and a plan year, an employer who employed an average of at least 101 employees on business days during the
preceding calendar year and who employs at least 1 employee on the first day of the plan year.”
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ACA TITLE
TITLE VI- Transparency
and program integrity

TITLE VII- Improving
access to innovative
medical therapies
TITLE VIII- Community
Living Assistance Services
and Supports Act (CLASS
Act)
TITLE IX- Revenue
provisions

TITLE X- Strengthening
quality, affordable health
care for all Americans
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Table 1. Key Features of the ACA Titles I-X (cont.)
Key Features
Stronger physician disclosure requirements, such as disclosure of physician
ownership-referrals, which foster transparency and protect American taxpayers
from fraud, waste, and abuse.
Identification of high-risk providers with fraud history and estoppel of penalized
providers seeking to transfer their services to other states.
Improved medical staff education programs that provide training on abuse
prevention.
Recovery Audit Contractor program expansion that serves to detect fraud and
abuse, and oversee payment exchanges.
Support for innovative, medically therapeutic programs that create monetary
savings across health systems and communities.
Extended discounts for prescription drugs and biologicals administered by health
care providers to adults and children in low income communities.
A national, voluntary, and self-funded insurance program (tax-payer free) that pays
for community assistance living services for disabled individuals.
Benefits may be used to support diverse forms of community support services,
such as home health care that allows disabled individuals to continue to work near
and live in their homes.
The ACA is intended to reduce the federal deficit and reduce tax-payer burden by
more than one hundred billion dollars by the year 2020.
Tax credits are intended to reduce health insurance premiums and financially
assist individuals and families with health insurance costs.
Revenue offset provisions seek to oversee and monitor improper health care
spending, such as excessive remuneration paid by certain health insurers, and
impose excise tax on considerably expensive employer-sponsored health
coverage.
Reauthorization of the Indian Health Care Improvement Act; provides Native
Americans with access to health care services.
Modernization of the Native American health care system with the goal to improve
health care for 1.9 million Native Americans.

The ACA- Looking Ahead
The ACA afforded health insurance coverage to individuals who were either underinsured or uninsured prior to the ACA’s
enactment. The purpose of the ACA is to increase the value of American healthcare and improve the overall health status of
individuals through the encouragement of population-based payments for rendered medical services, preventative and evidencebased medicine, and coordinated care. In essence, the ACA is a governmental measure and tool that is and can be used as a
conduit to attain and achieve health equity across income levels. Policies and programs implemented by virtue of the ACA have
great potential to decrease America’s “paradox of excess and deprivation” and address socioeconomic stereotypes and barriers
in healthcare.8
The ACA however, and as many know, is neither exempt from nor without limitations and critique. U.S. healthcare spending is
expected to increase as a result of 1) increased insurance plan enrollment through Health Insurance Exchanges and Medicaid
expansion, 2) a larger aging population, and 3) an improved economy. This increase in healthcare utilization has and will lead to
a “pent-up demand” for healthcare services in the marketplace, and increases in cost and payment for rendered medical
services.1,11 Many also accuse programs implemented by virtue of the ACA of interfering with and reducing the potential to introduce
stronger private market force and competition into the healthcare marketplace, and further accuse the ACA of merely strengthening
the market force of larger, wealthier, and better established health systems that have resources in place to implement complicated
value-based payment structures.12
Summary
Now that we have briefly explored and defined some of the types of policies and laws governing healthcare, financially and
clinically vulnerable populations, and future challenges and opportunities under the ACA, we may now summarize upon the
notion and need to balance the scales between bioethics and the marketplace. Inaction on current issues of excess and waste in
our healthcare system/marketplace and income inequality results in matters of life or death for millions, especially financially
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and/or clinically vulnerable populations that are less fortunate to achieve levels of wealth that would allow them the opportunity to
pay for expensive, yet medically necessary, medical procedures. As the U.S. market and economy improves, and as costs of
living rise as a result, it is important to identify and implement innovative ways to balance the scales between the two forces so
as to eliminate waste, reduce spending long-term for medially-necessary procedures, enhance patient education and access to
care, obtain social justice, and produce healthier patient populations.
Recommendations and Key Takeaways
Although marketplace concerns about the ACA are well warranted, it is important to understand the overarching need to reduce
waste and enhance quality and value, especially in healthcare. Costs are and can be astronomically high relative to individual
income, and families, employers, and communities alike are sorely impacted by poor public health outcomes that could be
prevented according to evidence-based medicine. Economic analysis projects a decrease in healthcare spending over time,
particularly after year 2023, as a result of measures put in place by ACA provisions, which include shifting healthcare payment
structures from fee-for-service payments that are volume-based to population-based payments that are value-based.1 Valuebased payments, also termed alternative payment models (APMs), distribute provider payments in accordance to value provided
to patient populations, versus the number of times the providers provide a tangible service. A significant number of APMs have
been developed and disseminated across a wide range of health networks and authorities, clinical specialties, and health
systems.
A key and laudable feature of APMs is that they promote high quality care at relatively lower costs for health consumers, and in
financially feasible ways for providers. The American Medical Association and Center for Healthcare Quality and Payment Reform
jointly outline three particular characteristics of successful, physician-focused APMs in their recently released Executive Summary
of APMs: 1) APM design must be flexible and must give providers the ability to deliver the most effective and efficient patient care
possible; 2) APMs must provide financial and tangible resources that allow its providers to deliver the highest quality care possible,
and distribute adequate, predictable, risk-adjusted payments that are tailored to the unique characteristics of its providers’ patient
populations; and 3) APM design must ensure, to patients and payers, that care costs will be either controlled or reduced so as to
not sacrifice quality for the sake of lower costs, and only hold providers accountable for care quality and costs that are exclusively
under the providers’ control. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) was created and implemented
by virtue of the ACA, and strongly encourages the use of such APMs.16,17
Examples of APMs include, but are not limited to, bundled or clinical episode payments and condition-based payments for physician
services. Bundled payments can be disease- or condition-specific, and may account for multi-specialty care delivered to unique
sets of patients undergoing specific courses of care. Condition-based payments for physician services are valuable in that
physicians have the flexibility to use effective and efficient treatment options, regardless of cost, if utilization of lower cost options
compromise patient care. The Clinical Episode Payment Work Group, as part of the Health Care Payment Learning and Action
Network (HCP LAN), published a white paper summarizing its formularies of and recommendations for condition-specific clinical
episode payments for elective joint replacement, maternity care, and coronary artery disease.18 Additional APMs endorsed by both
the CMS and Agency for Healthcare Research and Quality include Accountable Care Organizations (ACOs) and Patient Centered
Medical Homes (PCMHs).19,20
Given that value-based payment structures, or APMs, are a relatively new concept in U.S. healthcare, it is recommended that
stakeholders and stakeholder organizations collaborate and exchange ideas with one another in order to identify quality measures
and quality measurement tools and approaches. Programs such as the HCP LAN and Healthy People 2020, for example, have
been introduced by the CMS and the Office of Disease Prevention and Health Promotion, respectively, to facilitate collaboration
among communities and business sectors to exchange such ideas.13,14 These programs encourage shared decision making and
stakeholder engagement that must undeniably take place in order to balance the scales between the marketplace and public health
equity.
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